Literature DB >> 1818988

Validation of the SpaceLabs 90202 and 90207 devices for ambulatory blood pressure monitoring by comparison with intra-arterial resting and ambulatory measurements.

A Groppelli1, S Omboni, A Ravogli, A Villani, G Parati, G Mancia.   

Abstract

Mesh:

Year:  1991        PMID: 1818988

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


× No keyword cloud information.
  5 in total

1.  What is the magnitude of blood pressure response to a programme of moderate intensity exercise? Randomised controlled trial among sedentary adults with unmedicated hypertension.

Authors:  A R Cooper; L A Moore; J McKenna; C J Riddoch
Journal:  Br J Gen Pract       Date:  2000-12       Impact factor: 5.386

2.  The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension.

Authors:  A D Bainbridge; R J Macfadyen; S Stark; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

3.  Effectiveness of hydrochlorothiazide in combination with telmisartan and olmesartan in adults with moderate hypertension not controlled with monotherapy: a prospective, randomized, open-label, blinded end point (PROBE), parallel-arm study.

Authors:  Roberto Fogari; Annalisa Zoppi; Amedeo Mugellini; Paola Preti; Maurizio Destro; Andrea Rinaldi; Giuseppe Derosa
Journal:  Curr Ther Res Clin Exp       Date:  2008-02

4.  Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers.

Authors:  Daniele Bosone; Roberto Fogari; Annalisa Zoppi; Angela D'Angelo; Natascia Ghiotto; Giulia Perini; Matteo Cotta Ramusino; Alfredo Costa
Journal:  Eur J Clin Pharmacol       Date:  2018-04-30       Impact factor: 2.953

5.  A comparison of two ambulatory blood pressure monitors worn at the same time.

Authors:  Radhakrishna R Kallem; Kevin E C Meyers; Deirdre L Sawinski; Raymond R Townsend
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-08       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.